rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
13
|
pubmed:dateCreated |
2008-12-24
|
pubmed:abstractText |
The FASTER trial compared first and second trimester screening methods for aneuploidy. We examined relationships between maternal serum markers and common congenital anomalies in the pediatric outcome data set of 36 837 subjects.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-10051173,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-10451512,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-11943798,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-15791663,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-16055573,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-16055577,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-16282175,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-16832833,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-17230492,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-9061771,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19034930-9706645
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0197-3851
|
pubmed:author |
pubmed-author:BerkowitzRichard LRL,
pubmed-author:BianchiDiana WDW,
pubmed-author:BukowskiRadekR,
pubmed-author:CarrStephen RSR,
pubmed-author:CollinsJamieJ,
pubmed-author:ComstockChristine HCH,
pubmed-author:CraigoSabrina DSD,
pubmed-author:D'AltonMary EME,
pubmed-author:DugoffLorraineL,
pubmed-author:GrossSusan JSJ,
pubmed-author:HoffmanJodi DJD,
pubmed-author:MackinnonBrenda LBL,
pubmed-author:MaloneFergal DFD,
pubmed-author:NybergDavid ADA,
pubmed-author:PorterT FlintTF,
pubmed-author:SullivanLisa MLM,
pubmed-author:Timor-TritschIlan EIE,
pubmed-author:WolfeHonor MHM
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1204-8
|
pubmed:dateRevised |
2011-7-28
|
pubmed:meshHeading |
pubmed-meshheading:19034930-Adult,
pubmed-meshheading:19034930-Case-Control Studies,
pubmed-meshheading:19034930-Chorionic Gonadotropin, beta Subunit, Human,
pubmed-meshheading:19034930-Cohort Studies,
pubmed-meshheading:19034930-Down Syndrome,
pubmed-meshheading:19034930-Estriol,
pubmed-meshheading:19034930-Female,
pubmed-meshheading:19034930-Humans,
pubmed-meshheading:19034930-Infant, Newborn,
pubmed-meshheading:19034930-Inhibins,
pubmed-meshheading:19034930-Male,
pubmed-meshheading:19034930-Multicystic Dysplastic Kidney,
pubmed-meshheading:19034930-Nuchal Translucency Measurement,
pubmed-meshheading:19034930-Pregnancy,
pubmed-meshheading:19034930-Pregnancy-Associated Plasma Protein-A,
pubmed-meshheading:19034930-Prenatal Diagnosis,
pubmed-meshheading:19034930-Prospective Studies,
pubmed-meshheading:19034930-Testicular Hydrocele,
pubmed-meshheading:19034930-alpha-Fetoproteins
|
pubmed:year |
2008
|
pubmed:articleTitle |
Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele.
|
pubmed:affiliation |
Tufts Medical Center, Boston, MA 02111, USA.
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Research Support, N.I.H., Extramural
|